investegate.co.uk
Neutralwww.investegate.co.uk · · GB
Director Pdmr Shareholding Share Purchase
WoundWoundsUlcersExecutive Officer
Executive Summary
AI-generatedThe company announced that Mr Richard Cotton, a Senior Independent Director, and Mrs Jane Cotton-Hall purchased a total of 49,110 common shares. These purchases were made in two transactions on June 17th and June 18th, 2026, at varying prices per share. Following these acquisitions, their combined beneficial holding increased to 264,540 common shares, representing about 0.25% of the company's total issued capital.
Key Insights
- Mr Richard Cotton and Mrs Jane Cotton-Hall acquired a total of 49,110 common shares in AOTI, INC.
- The purchases occurred on June 17th and June 18th, 2026, at prices of 60 pence and 62 pence per share, respectively.
- Their combined beneficial interest in the company rose to 264,540 common shares, equating to roughly 0.25% of issued capital.
- AOTI, INC., founded in 2006, develops treatments for chronic wounds using its patented Topical Wound Oxygen (TWO2®) therapy.
- The TWO2® therapy has received regulatory clearances from major markets including the US, Europe, UK, and Australia.
Topic context
Related topics
The full article is on the original publisher site.